First patient enrolled in Delcath amended registration trial in metastatic ocular melanoma
Delcath Systems announces that the first patient has been enrolled under the amended protocol for its registration trial in ocular melanoma liver metastases. Stanford University Medical Center is the first trial site to enroll a patient under the amended protocol. August 21, 2018